Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Other Solid Tumors 472

472 - Histopathologic correlation with 68Ga PSMA PET/CT in Non Prostate Tumors. (ID 522)

Session Name
PSMA and DCFPyL
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> Other Solid Tumors
Presentation Number
472

Previous Eposter
471 - Synthesis and preclinical evaluation of a molecular probe for imaging lung cancer with L858R/T790M mutation of epidermal growth factor receptor (EGFR) (ID 340)

Next Eposters
473 - Clinical Application of SPECT-CT Imaging with 99mTc/PSMA T4 in patients with Recurrent Prostate Cancer (ID 523)
474 - A Pilot Study on 68Ga-PSMA-11 PET/CT in Assessing Metastatic Clear Cell Renal Cell Carcinoma (ID 521)
475 - 68Ga-PSMA PET/MRI for the Diagnoses of Primary and Biochemical Recurrent Prostate Cancer: A System Review and Meta-Analysis (ID 520)
477 - [18F]DCFPyL associated radioactivity in patient saliva samples. (ID 527)
484 - Imaging characteristics and diagnostic performance of 18F-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy (ID 547)
486 - 18F-FDG PET/CT in prognostication of malignant peripheral nerve sheath tumors. (ID 551)
487 - Prognostic and predictive interest of 18F-FDG PET/CT in the initial assessment of stage III B-C-D and IV patients with melanoma before anti-PD-1 immunotherapy. (ID 545)
489 - Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy (ID 546)
490 - Role of 18F-FDG PET/CT Imaging in Cardiac Masses (ID 550)
490a - Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer (ID 572)